See every side of every news story
Published loading...Updated

Protein Disulfide Isomerase Could Be Therapeutic Target for MF

Summary by Rare Disease Advisor
Protein disulfide isomerase may be involved in the pathogenesis of thrombotic events in Philadelphia-negative myeloproliferative neoplasms, such as MF. The post Protein Disulfide Isomerase Could Be Therapeutic Target for MF appeared first on Rare Disease Advisor
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Rare Disease Advisor broke the news in on Tuesday, March 11, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.